HGF/MET-Modulating Compounds for Neuropathy Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for improved compounds and methods to modulate HGF/MET signaling activity for the treatment of neuropathies such as polyneuropathies and mononeuropathies, as highly efficacious therapeutics in this area have not been fully explored.
Innovation Solution
Development of compounds that modulate HGF activity for treating neuropathies, including administering effective amounts of specific compounds of Formula (I) or their pharmaceutically acceptable salts, isotopic forms, or stereoisomers, which are optionally substituted with various functional groups to target HGF/MET signaling pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapies are used for neuropathies, then treatment options are limited, but therapeutic efficacy is insufficient
Solution Approach 1:
The patent employs parameter changes by systematically varying chemical structures of compounds (Formula I with different L, R1a, R1b, R2, R3, R4, R5, R6, R7, m, n parameters) to optimize HGF/MET signaling modulation. This allows generating multiple therapeutic compounds with different efficacies and profiles, resolving the contradiction between limited treatment options and insufficient efficacy by creating a family of optimized compounds with tailored properties.
2Reliability
If HGF/MET signaling is modulated to treat neuropathies, then therapeutic benefits are achieved, but highly efficacious compounds have not been fully explored
Solution Approach 1:
The patent applies segmentation by dividing the HGF/MET modulator development into systematic structural segments (Formula I with defined variable groups L, R1a, R1b, R2, R3, R4, R5, R6, R7, m, n). This segmented approach allows methodical exploration and optimization of compound efficacy while maintaining manageable development processes, resolving the contradiction between achieving therapeutic benefits and the difficulty of comprehensive compound exploration.
Data Source
AI summary
Provided herein are compounds and compositions thereof for modulating hepatocyte growth factors. In some embodiments, the compounds and compositions are provided for treatment of diseases, including neuropathies.